Modern genetics offers the potential to revolutionize medicine. Genetic privacy also raises some of the toughest regulatory challenges of the 21st Century. This session looks at the practical challenges faced by life science businesses when developing necessary privacy programs. It focuses on law, regulations, and ethics as developing in Europe and the U.S.

Michael G. Hamilton, Chief Privacy Officer, Invitae
Maria Chiara Atzori, Head of Data Privacy, Novartis (Switzerland)

Room 307

Michael Hamilton
Michael Hamilton

Chief Privacy Officer
Invitae

Maria Chiara
Maria Chiara Atzori

Head of Data Privacy
Novartis
(Switzerland)